Spread Betting

GE begins human trials for cancer detection agent

Financial Spread Trading By WTN News • 06/07/06 Madison, Wis. - Medical imaging technology provider GE Healthcare announced it has begun clinical trials of a new molecular imaging agent for the detection of cancer.

Breast cancer cases in women are estimated to total more than 178, 480 and result in more than 40, 460 deaths according to the American Cancer Society. Though new methods for breast cancer detection are being developed and breast cancer survival rates are increasing, there is still a need to spread awareness and raise funds for breast cancer research. Right now there is no way to prevent breast cancer, but early detection gives breast cancer patients the best chance for survival. exams and yearly mammograms are two of the best methods for early breast cancer detection.

Nfl Betting Spread The agent, which uses positron emission tomography (PET), is designed to track the process of angiogenesis, or the formation of new blood vessels in the body. It will be used to quantify therapy for Stage IV metastatic tumors in breast cancer patients, before and after chemotherapy.

Rating Discuss recent research regarding the role of dioxin as a possible causative agent in birth defects, cancer, liver and thymus damage, and immune system suppression in humans..

Commodity Spread Trading In a PET treatment, patients are injected with small amounts of radiopharmaceuticals, which create images of tissue chemical changes that could be early warning signs of cancer. Uses for the radiopharmaceuticals include spotting changes in glucose metabolism, monitoring the effectiveness of drug therapy during cancer treatments, and tracking whether tumors are diverting new blood vessels to sustain their growth.

(HealthDay News) - Here are the latest clinical trials, courtesy of Breast Cancer This is a clinical study to test safety and efficacy of an experimental drug designed to treat advanced breast cancer. Those who may qualify for the trial are women at least 18 years old who have metastatic or locally unresectable advanced breast cancer and have not had other cancers in the last 3 years (excluding basal or squamous cell skin cancer, or cervical cancer) or cancer that has spread to the brain. feeding.

Betting Exchange Spread The research is being overseen at the Hammersmith Hospital in London by David Brooks, chief medical officer of GE Imanet, which handles GE Healthcare's international network of imaging research centers.

detection problem, this time specifically for lung cancer, the leading cancer killer in the United States. year survival rate for lung cancer, which is rarely detected early, is a very low 15 percent. But, if detection can be made early, survival rates of 50 percent have been seen. Researchers from Panacea Pharmaceuticals of Gaithersburg, Md., have developed a blood test that targets a protein called human aspartyl (asparaginyl) hydroxylase (HAAH), which appears on the surface of cancer cells and in the blood of people with cancer.

Advanced Commodity Spread GE Healthcare is a division of General Electric. The company manufactures medical imaging technology at its Waukesha headquarters, GE Healthcare Technologies, and its Milwaukee location, GE Healthcare Information Technologies.

Manish Aghi, M.D., Ph.D., of the Massachusetts General Hospital in Boston, and colleagues paired temozolomide with an oncolytic, or cancer killing, genetically engineered form of the herpes simplex virus called G207. They tested both agents together and separately in cancer cells and in mice with gliomas. Their laboratory studies on human cancer cells found that the virus and the drug act synergistically in cancer cells to promote cell death. Mice with brain gliomas treated with both the virus and the drug survived more than twice as long as those treated with either agent alone.

Online Spread Betting Related stories

Stock Spread Trading Michael Rosen: Midwest retains dominant role in 2005 world medical device market

Betting Horse Racing Spread GE announces first installation of Discovery VCT

Complete Guide Spread Trading GE, St. Jude to collaborate on visualization technology

[ Comment, Edit or Article Submission ]